Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, deFilippi CR, et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation. 2012  ;126(25):2951-61.

Kizer JR, Arnold AM, Benkeser D, Ix JH, Djoussé L, Zieman SJ, Barzilay JI, Tracy RP, Mantzoros CS, Siscovick DS, et al. Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care. 2012  ;35(2):415-23.

Djoussé L, Benkeser D, Arnold A, Kizer JR, Zieman SJ, Lemaitre RN, Tracy RP, Gottdiener JS, Mozaffarian D, Siscovick DS, et al. Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study. Circ Heart Fail. 2013  ;6(5):964-9.

Kizer JR, Benkeser D, Arnold AM, Djoussé L, Zieman SJ, Mukamal KJ, Tracy RP, Mantzoros CS, Siscovick DS, Gottdiener JS, et al. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab. 2013  ;98(1):255-63.

Kizer JR, Benkeser D, Arnold AM, Ix JH, Mukamal KJ, Djoussé L, Tracy RP, Siscovick DS, Psaty BM, Zieman SJ. Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults. Atherosclerosis. 2014  ;235(1):116-21.

Karas MG, Benkeser D, Arnold AM, Bartz TM, Djoussé L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, et al. Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ?65 years of age (from the Cardiovascular Health study). Am J Cardiol. 2014  ;113(2):328-34.